WallStreetZenWallStreetZen

NASDAQ: NKGN
Nkgen Biotech Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

NKGN past revenue growth

How has NKGN's revenue growth performed historically?
Company
-100%
Industry
144.63%
Market
17.55%
NKGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
NKGN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

NKGN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$83.0M
Current Profit Margin
0%

NKGN Return on Equity

Insufficient data to display

Be the first to know when NKGN announces earnings.

NKGN Return on Assets

Current Company
-416%
Current Industry
2.9%
NKGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

NKGN Return on Capital Employed

Current Company
357.85%
Current Industry
19.5%

NKGN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
NKGN$0.00-$80.64M-$82.95M-100.00%N/A
BCLI$0.00-$16.48M-$17.19MN/AN/A
ESLA$0.00-$8.36M-$8.36MN/AN/A
CARA$20.97M-$115.58M-$118.51M+9.26%N/A
PMN$0.00-$12.99M-$13.21MN/AN/A
View Top Biotech Stocks

Nkgen Biotech Earnings & Revenue FAQ

What were NKGN's earnings last quarter?

Nkgen Biotech (NASDAQ: NKGN) reported Q4 2023 earnings per share (EPS) of -$1.68, up 88.76% year over year. Total Nkgen Biotech earnings for the quarter were -$33.61 million. In the same quarter last year, Nkgen Biotech's earnings per share (EPS) was -$0.89.

If you're new to stock investing, here's how to buy Nkgen Biotech stock.

What was NKGN's earnings growth in the past year?

As of Q2 2024, Nkgen Biotech's earnings has grown year over year. Nkgen Biotech's earnings in the past year totalled -$82.95 million.

What was NKGN's revenue last quarter?

Nkgen Biotech (NASDAQ: NKGN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Nkgen Biotech's revenue was $0.00.

What was NKGN's revenue growth in the past year?

As of Q2 2024, Nkgen Biotech's revenue has grown -100% year over year. This is 244.63 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Nkgen Biotech's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.